Corbo, Junard S.

HRN: 23 44 03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2023
CEFTAZIDIME 1GM (VIAL)
07/24/2023
07/30/2023
IV
1gm
Q8
CAP PTB
Waiting Final Action 
07/24/2023
AZITHROMYCIN 500MG TABLET (TAB)
07/24/2023
07/28/2023
PO
500mg
OD
CAP PTB
Waiting Final Action 
07/29/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/29/2023
07/29/2023
IV
4.5g
Once
Sepsis Sec To CAP
Waiting Final Action 
07/29/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/29/2023
08/04/2023
IV
2.25g
Q6h
Sepsis Sec To CAP
Waiting Final Action 
07/29/2023
CEFTAZIDIME 1GM (VIAL)
07/29/2023
08/04/2023
IV
2g
Q8h
Sepsis Sec To CAP
Waiting Final Action 
08/01/2023
MUPIROCIN 2%, 15G (TUBE)
08/01/2023
08/07/2023
TOPICAL
Apply Bid
BID
Leg Ulcer
Waiting Final Action 
08/01/2023
COTRIMOXAZOLE 960MG (TAB)
08/01/2023
08/07/2023
PO
960mg
BID
Pneumonia In Immunocompromised Host
Waiting Final Action 
08/07/2023
CEFTAZIDIME 1GM (VIAL)
08/07/2023
08/13/2023
IV
2 G
Q8
Pneumonia /sepsis
Waiting Final Action 
08/11/2023
LEVOFLOXACIN 500MG (TAB)
08/11/2023
08/17/2023
PER NGT
1 And 1/2 Tab
OD
Sepsis, Pneumonia
Waiting Final Action 
08/16/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/16/2023
08/22/2023
IV
4.5 Grams
Q 8 Hours
Sepsis
Waiting Final Action 
09/09/2023
CEFTRIAXONE 1G (VIAL)
09/09/2023
09/15/2023
IV
2g
Q24
Complicated UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: